Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases

por Maria Gałuszko-Wȩgielnik, Adam Włodarczyk, Wiesław Jerzy Cubała, Alina Wilkowska, Natalia Górska, Jakub Słupski
Publicado 2021

Novel Insights Into the Neurobiology of the Antidepressant Response From Ketamine Research: A Mini Review

por Michael Colla, Hanne Scheerer, Steffi Weidt, Erich Seifritz, Golo Kronenberg
Publicado 2021

Cognitive impairments in treatment-resistant depression: Results from the French cohort of outpatients (FACE-DR)

por A Vancappel, Y Dansou, O Godin, E Haffen, A Yrondi, F Stéphan, R Richieri, F Molière, M Horn, E Allauze, JB Genty, A Bouvard, JM Dorey, M Meyrel, V Camus, G Fond, B Péran, M Walter, L Anguill, C Scotto d'Apollonia, AS Nguon, B Fredembach, J Holtzmann, E Vilà, J Petrucci, Rey, B Etain, M Carminati, P Courtet, G Vaiva, PM Llorca, M Leboyer, B Aouizerate, D Bennabi, W El-Hage
Publicado 2021

Management of Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia

por Wang G, Han C, Liu CY, Chan S, Kato T, Tan W, Zhang L, Feng Y, Ng CH
Publicado 2020

An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression

por Sherry-Anne Muscat, Sherry-Anne Muscat, Glenn Hartelius, Courtenay Richards Crouch, Kevin W. Morin, Kevin W. Morin
Publicado 2021

Definition and Identification of Patients with Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia

por Han C, Wang G, Chan S, Kato T, Ng CH, Tan W, Zhang L, Feng Y, Liu CY
Publicado 2020

A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression

por Sugawara H, Sakamoto K, Harada T, Shimizu S, Ishigooka J
Publicado 2016

Clinical Features and Outcomes of 124 Italian Patients With Treatment Resistant Depression: A Real-World, Prospective Study

por Giulio Perugi, Paola Calò, Sergio De Filippis, Gianluca Rosso, Gianluca Rosso, Antonio Vita, Antonio Vita, Marina Adami, Giuseppe Ascione, Joachim Morrens, Dario Delmonte
Publicado 2021

Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials

por Luan SX, Wan HQ, Zhang L, Zhao H
Publicado 2018

Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials

por Borentain S, Williamson D, Turkoz I, Popova V, McCall WV, Mathews M, Wiegand F
Publicado 2021

Addictive potential of novel treatments for refractory depression and anxiety

por Kolar D
Publicado 2018

Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials

por Luan S, Wan H, Wang S, Li H, Zhang B
Publicado 2017

BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study

por Huang XB, Huang X, He HB, Mei F, Sun B, Zhou SM, Yan S, Zheng W, Ning Y
Publicado 2020

Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy ver...

por Zafiris J. Daskalakis, Carol Tamminga, Alanah Throop, Lucy Palmer, Julia Dimitrova, Faranak Farzan, Kevin E. Thorpe, Shawn M. McClintock, Daniel M. Blumberger
Publicado 2021

Comparative Study of Cognitive Function Between Treatment-Resistant Depressive Patients and First-Episode Depressive Patients

por Rao D, Xu G, Lu Z, Liang H, Lin K, Tang M
Publicado 2019

Vagus Nerve Stimulation For Treatment Resistant Depression: Case Series Of Six Patients - Retrospective Efficacy And Safety Observation After One Year Follow Up

por Kucia K, Merk W, Zapalowicz K, Medrala T
Publicado 2019

Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review

por Correia-Melo FS, Argolo FC, Araújo-de-Freitas L, Leal GC, Kapczinski F, Lacerda AL, Quarantini LC
Publicado 2017

Management of Treatment-Resistant Depression: Challenges and Strategies

por Voineskos D, Daskalakis ZJ, Blumberger DM
Publicado 2020

Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression

por Kumar A, Bunker MT, Aaronson ST, Conway CR, Rothschild AJ, Mordenti G, Rush AJ
Publicado 2019

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression

por Szarmach J, Cubała WJ, Włodarczyk A, Gałuszko-Węgielnik M
Publicado 2020